Effects of Ipratropium Bromide Combined with Traditional Chinese Medicine Intervention on the Pulmonary Function and Psychological Status of Patients with Chronic Obstructive Pulmonary Disease

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2023 Feb 17

PMID 36798728

Authors

Wen-Yi Ye

Hong Zhao

Jing Ye

Hai-Jin Sang

Lin-Shui Zhou

Jia-Ni Lv

Juan-Juan Li

Affiliations

Soon will be listed here.

Abstract

Recently, most scholars have advocated multidisciplinary comprehensive intervention measures for chronic obstructive pulmonary disease (COPD) to improve lung function, relieve symptoms of dyspnea, and improve quality of life. Traditional Chinese medicine (TCM) has rich experience in the treatment of various respiratory system diseases and the rehabilitation of their syndrome differentiation. In this study, total 68 patients with COPD from November 2019 to November 2021 in the hospitals were divided into the control group, ipratropium bromide (IB)-treated group, and IB + TCM-treated group for clinical efficacy observation and to explore the effect of IB combined with TCM on the pulmonary function and psychological status of COPD patients. Patients in the control group were subjected to routine oxygen inhalation, cough and expectorant, and antiviral treatments, while the patients in the IB-treated group were treated with IB and those received in the control group. Patients in the IB + TCM-treated group were treated with IB and TCM intervention. All patients were treated for a month. The results showed that after different interventions, the levels of FEV1, FEV1% pred, FVC, and PEF ( < 0.05) were significantly increased in all the groups, while levels of TNF-, IL-6, IL-8, and CRP in serum as well as Hamilton Anxiety Scale and Hamilton Depression scores were significantly decreased. Compared with the control group and IB-treated group, the IB + TCM-treated group presented the greatest changes on all abovementioned indicators and the lowest total incidence of adverse reactions, indicating the biggest improvement of IB + TCM on the symptoms of COPD patients. Therefore, the combination of IB and TCM intervention effectively improved the pulmonary function and psychological status of COPD patients and could be used as an important adjunct for COPD treatment.

Citing Articles

Effect of high-flow nasal oxygen therapy combined with ipratropium bromide on Th1/Th2 balance and inflammation in patients with chronic obstructive pulmonary disease and respiratory failure.

Li T, Xu X Pak J Med Sci. 2024; 40(9):1979-1984.

PMID: 39416610 PMC: 11476147. DOI: 10.12669/pjms.40.9.10221.

References

Johansen M, Mahbub R, Idrees S, Nguyen D, Miemczyk S, Pathinayake P . Increased SARS-CoV-2 Infection, Protease, and Inflammatory Responses in Chronic Obstructive Pulmonary Disease Primary Bronchial Epithelial Cells Defined with Single-Cell RNA Sequencing. Am J Respir Crit Care Med. 2022; 206(6):712-729. PMC: 9799113. DOI: 10.1164/rccm.202108-1901OC. View

Wang L, Chen X, Li X, Liu D, Wang X, Chang X . Developing a novel strategy for COPD therapy by targeting Nrf2 and metabolism reprogramming simultaneously. Free Radic Biol Med. 2021; 169:436-445. DOI: 10.1016/j.freeradbiomed.2021.03.039. View

Reaves C, Angosta A . The relaxation response: Influence on psychological and physiological responses in patients with COPD. Appl Nurs Res. 2020; 57:151351. DOI: 10.1016/j.apnr.2020.151351. View

Wang H, Hou Y, Ma X, Cui L, Bao Y, Xie Y . Multi-omics analysis reveals the mechanisms of action and therapeutic regimens of traditional Chinese medicine, Bufei Jianpi granules: Implication for COPD drug discovery. Phytomedicine. 2022; 98:153963. DOI: 10.1016/j.phymed.2022.153963. View

Zhao S, Wang H, Zhang C, Hu J, Zhuang L, Wang X . Repeated Herbal Acupoint Sticking Relieved the Recurrence of Allergic Asthma by Regulating the Th1/Th2 Cell Balance in the Peripheral Blood. Biomed Res Int. 2020; 2020:1879640. PMC: 7251437. DOI: 10.1155/2020/1879640. View

Haifeng W, Hailong Z, Jiansheng L, Xueqing Y, Suyun L, Bin L . Effectiveness and safety of traditional Chinese medicine on stable chronic obstructive pulmonary disease: A systematic review and meta-analysis. Complement Ther Med. 2015; 23(4):603-11. DOI: 10.1016/j.ctim.2015.06.015. View

Agusti A, Hogg J . Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease. N Engl J Med. 2019; 381(13):1248-1256. DOI: 10.1056/NEJMra1900475. View

Yang Y, Jin X, Jiao X, Li J, Liang L, Ma Y . Advances in Pharmacological Actions and Mechanisms of Flavonoids from Traditional Chinese Medicine in Treating Chronic Obstructive Pulmonary Disease. Evid Based Complement Alternat Med. 2021; 2020:8871105. PMC: 7790571. DOI: 10.1155/2020/8871105. View

Xiong C, Li Y, Zhuang G, Zeng Y, Wei H, Li C . Clinical efficacy and safety of Chinese herbal medicine versus placebo for the treatment of chronic obstructive pulmonary disease: A systematic review and meta-analysis. Complement Ther Med. 2021; 59:102691. DOI: 10.1016/j.ctim.2021.102691. View

10.

Ye X, Luo S, Chang X, Fang Y, Liu Y, Zhang Y . Extract Alleviates COPD by Inhibiting the Inflammatory Response via Downregulation of NF-κB. Molecules. 2022; 27(23). PMC: 9737274. DOI: 10.3390/molecules27238243. View

11.

Liu Q, Duan H, Lian A, Zhuang M, Zhao X, Liu X . Rehabilitation Effects of Acupuncture on the Diaphragm Dysfunction in Chronic Obstructive Pulmonary Disease: A Systematic Review. Int J Chron Obstruct Pulmon Dis. 2021; 16:2023-2037. PMC: 8275099. DOI: 10.2147/COPD.S313439. View

12.

Engelen M, Jonker R, Sulaiman H, Fisk H, Calder P, Deutz N . ω-3 polyunsaturated fatty acid supplementation improves postabsorptive and prandial protein metabolism in patients with chronic obstructive pulmonary disease: a randomized clinical trial. Am J Clin Nutr. 2022; 116(3):686-698. PMC: 9437982. DOI: 10.1093/ajcn/nqac138. View

13.

Qian Y, Yan L, Wei M, Song P, Wang L . Seeds of Ginkgo biloba L. inhibit oxidative stress and inflammation induced by cigarette smoke in COPD rats through the Nrf2 pathway. J Ethnopharmacol. 2022; 301:115758. DOI: 10.1016/j.jep.2022.115758. View

14.

Mwasuku C, King J, Russell R, Bafadhel M . Renaming COPD exacerbations: the UK respiratory nursing perspective. BMC Pulm Med. 2021; 21(1):299. PMC: 8459136. DOI: 10.1186/s12890-021-01662-9. View

15.

Ritzmann F, Lunding L, Bals R, Wegmann M, Beisswenger C . IL-17 Cytokines and Chronic Lung Diseases. Cells. 2022; 11(14). PMC: 9318387. DOI: 10.3390/cells11142132. View

16.

Mao Y, Hu G, Meng Q, Li X, Sun X, Zhou J . Efficacy of Shenling Baizhu San on stable chronic obstructive pulmonary disease patients: A systematic review and meta-analysis. J Ethnopharmacol. 2021; 272:113927. DOI: 10.1016/j.jep.2021.113927. View

17.

Xiao T, Wijnant S, van der Velpen I, Terzikhan N, Lahousse L, Ikram M . Lung function impairment in relation to cognition and vascular brain lesions: the Rotterdam Study. J Neurol. 2022; 269(8):4141-4153. DOI: 10.1007/s00415-022-11027-9. View

18.

Li X, Obeidat M, Zhou G, Leung J, Tashkin D, Wise R . Responsiveness to Ipratropium Bromide in Male and Female Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease. EBioMedicine. 2017; 19:139-145. PMC: 5440622. DOI: 10.1016/j.ebiom.2017.04.020. View

19.

Chan K, Tsoi Y, McCall M . The Effectiveness of Traditional Chinese Medicine (TCM) as an Adjunct Treatment on Stable COPD Patients: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med. 2021; 2021:5550332. PMC: 8195656. DOI: 10.1155/2021/5550332. View

20.

Yang L, Zhong D, Zhang Y, Li Y, Liu T, Zheng Y . Tai Chi for Chronic Obstructive Pulmonary Disease (COPD): An Overview of Systematic Reviews. Int J Gen Med. 2021; 14:3017-3033. PMC: 8254601. DOI: 10.2147/IJGM.S308955. View